BRPI0806411B8 - processo para a preparação de um composto e compostos - Google Patents

processo para a preparação de um composto e compostos

Info

Publication number
BRPI0806411B8
BRPI0806411B8 BRPI0806411A BRPI0806411A BRPI0806411B8 BR PI0806411 B8 BRPI0806411 B8 BR PI0806411B8 BR PI0806411 A BRPI0806411 A BR PI0806411A BR PI0806411 A BRPI0806411 A BR PI0806411A BR PI0806411 B8 BRPI0806411 B8 BR PI0806411B8
Authority
BR
Brazil
Prior art keywords
hydroxy
preparing
compounds
compound
methylethyl
Prior art date
Application number
BRPI0806411A
Other languages
English (en)
Inventor
Pivetti Fausto
Delcanale Maurizio
Bocchi Monica
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of BRPI0806411A2 publication Critical patent/BRPI0806411A2/pt
Publication of BRPI0806411B1 publication Critical patent/BRPI0806411B1/pt
Publication of BRPI0806411B8 publication Critical patent/BRPI0806411B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

processo para a preparação de 8-hydroxy-5-((1 r)-1-hydroxy-2(((1 r)-2-(4-methoxyphenyl)-1 -methylethyl)amino)ethyl)-2(1 h)-quinolinone monohydrochloride. esta invenção relaciona-se a um processo para a preparação de8-hydroxy-5-((1 r)-1-hydroxy-2((( 1r)-2-(4-methoxyphenyly- 1 -methylethyl) amino) ethyl)-2(1h)-quinolinone monohydrochloride. substâncias intermediárias do processo são também divulgadas neste relatório.
BRPI0806411A 2007-01-30 2008-01-22 processo para a preparação de um composto e compostos BRPI0806411B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07001950.0 2007-01-30
EP07001950A EP1953143A1 (en) 2007-01-30 2007-01-30 Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
PCT/IB2008/000134 WO2008093188A1 (en) 2007-01-30 2008-01-22 Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1h)-quinolinone monohydrochloride

Publications (3)

Publication Number Publication Date
BRPI0806411A2 BRPI0806411A2 (pt) 2011-09-06
BRPI0806411B1 BRPI0806411B1 (pt) 2020-10-13
BRPI0806411B8 true BRPI0806411B8 (pt) 2021-05-25

Family

ID=38055152

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0806411A BRPI0806411B8 (pt) 2007-01-30 2008-01-22 processo para a preparação de um composto e compostos

Country Status (14)

Country Link
US (1) US8163922B2 (pt)
EP (2) EP1953143A1 (pt)
JP (1) JP2010516803A (pt)
KR (1) KR101404263B1 (pt)
CN (1) CN101611010B (pt)
AU (1) AU2008211655B2 (pt)
BR (1) BRPI0806411B8 (pt)
CA (1) CA2676849C (pt)
EA (1) EA018170B1 (pt)
ES (1) ES2409740T3 (pt)
HK (1) HK1135093A1 (pt)
MX (1) MX2009007868A (pt)
WO (1) WO2008093188A1 (pt)
ZA (1) ZA200905291B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR048339A1 (es) * 2004-03-24 2006-04-19 Chiesi Farma Spa Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion
EP2116537A1 (en) * 2008-05-07 2009-11-11 CHIESI FARMACEUTICI S.p.A. Polymorph of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
PL3092217T3 (pl) 2014-01-09 2020-11-16 Davuluri, Ramamohan Rao Nowy sposób wytwarzania indakaterolu lub jego farmaceutycznie dopuszczalnych soli

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
AR048339A1 (es) 2004-03-24 2006-04-19 Chiesi Farma Spa Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion

Also Published As

Publication number Publication date
US8163922B2 (en) 2012-04-24
EA200900926A1 (ru) 2010-02-26
EP2109603A1 (en) 2009-10-21
HK1135093A1 (pt) 2010-05-28
CN101611010A (zh) 2009-12-23
US20090326231A1 (en) 2009-12-31
JP2010516803A (ja) 2010-05-20
AU2008211655A1 (en) 2008-08-07
KR101404263B1 (ko) 2014-06-05
ES2409740T3 (es) 2013-06-27
AU2008211655B2 (en) 2013-04-04
CA2676849C (en) 2015-12-15
CA2676849A1 (en) 2008-08-07
BRPI0806411A2 (pt) 2011-09-06
EA018170B1 (ru) 2013-06-28
EP2109603B1 (en) 2013-04-03
EP1953143A1 (en) 2008-08-06
WO2008093188A1 (en) 2008-08-07
CN101611010B (zh) 2012-03-21
KR20090104820A (ko) 2009-10-06
BRPI0806411B1 (pt) 2020-10-13
ZA200905291B (en) 2010-10-27
MX2009007868A (es) 2009-07-31

Similar Documents

Publication Publication Date Title
DK2046726T3 (da) Fremstilling af (2R,3R)-3-3-methoxyphenyl)-N,N, 2-trimethylpentanamin
CL2007002949A1 (es) Forma cristalina del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluoro-n-((metil(1-metiletil)amino)sulfonil)benzamida; proceso para la preparacion de dicha forma cristalina; composicion fitoprotectora;
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
BRPI0714558B8 (pt) processo para a preparação de (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol
BRPI0806411B8 (pt) processo para a preparação de um composto e compostos
WO2008000418A3 (en) New method for salt preparation
BRPI0506823A (pt) derivados de aril anilina como agonistas de receptor beta2 adrenérgico
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0612620A2 (pt) composição de catalisador, método para a fabricação da mesma, e, processo para a hidrogenação de um composto nitro orgânico ou nitrila na amina correspodente
BR112013018975A2 (pt) processo para o preparo de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos
BRPI0507308A (pt) nanossuspensões de agentes anti-retrovirais para entrega ao sistema nervoso central aumentada
WO2012056458A3 (en) Intermediate compounds and process for the preparation of fingolimod
EA201100759A1 (ru) Арилоазол-2-илцианоэтиламиносоединения противопаразитарного действия, обогащенные одним из энантиомеров
CA2495628A1 (fr) Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl)acetonitrile et application a la synthese de l'agomelatine
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
EA200870038A1 (ru) Способ получения аминов
WO2011144983A3 (en) An improved process for the preparation of lacosamide
BRPI0919635A8 (pt) Processo para preparação de cinacalcet
CL2008003358A1 (es) Hidratos cristalinos de n-(4((2s,3r)-3-((s)-3-(4-fluorofenil)-3-hidroxipropil)-2-(4-metoxifenil)4-oxoazetidin-1-il)bencil)-n-((2s,3r,4r,5r)-2,3,4,5,6-pentahidroxihexil)dodecandiamida; procedimiento de preparacion de dicho compuesto; composiicon farmaceutica que lo comprende; y uso para tratar trastornos del metabolismo de lipidos.
ITMI20050249A1 (it) Procedimento per la preparazione di tolterodina
AR048339A1 (es) Monoclorhidrato de 8- hidroxi-5-((1r)) -1- hidroxi-2- (((1r)-2 ( 4-metoxifenil) -1- metiletil) amino ) eti l) -2 (1h) - quinolinona en form acristalina y el proceso para su preparacion
EA201300719A2 (ru) Способ ферментативного синтеза (7s)-1-(3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил) n-метилметанамина и применение в синтезе ивабрадина и его солей
WO2013179298A3 (en) A process for preparation of phenyl carbamate derivative and polymorphic forms thereof
WO2009084031A3 (en) An improved process for preparation of (2e)-2-cyano-3-(3,4- dihydroxy-5-nitrophenyl)n,n-diethyl-2-propenamide polymorphic form a
CL2009000346A1 (es) Compuestos derivados de pirimidilmetilsulfonamida; procedimiento para preparar dichos compuestos; compuesto intermediario de formula ixa; composicion agroquimica; metodo para combatir hongos daninos fitopatogenos, y uso de dichos compuestos.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: REFERENTE A RPI 2282 DE 30/09/2014

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/01/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2706 DE 16-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.